OPKO Health (MEX:OPK) Current Deferred Revenue: MXN0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:OPK OPKO Health Inc MEX:OPK
44 GF Score
Price MXN26.20
GF Value MXN14.54
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is OPKO Health Current Deferred Revenue?

OPKO Health MEX:OPK 44 Current Deferred Revenue is MXN0 Mil as of Jun. 2026. GuruFocus rates MEX:OPK with a GF Score™ of 44/100 and a GF Value™ of MXN14.54 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

OPKO Health's current deferred revenue for the quarter that ended in Jun. 2026 was MXN0 Mil.

OPKO Health Current Deferred Revenue Related Terms

OPKO Health Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for OPKO Health's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OPKO Health Current Deferred Revenue Chart

OPKO Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.29 0.00 0.00 0.00 0.00

OPKO Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:OPK
44GF Score
OPKO Health Inc MEX:OPK
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of MXN0 Mil mean?
OPKO Health (MEX:OPK) has a Current Deferred Revenue of MXN0 Mil as of Jun. 2026. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on OPKO Health and its competitors.
Is OPKO Health's Current Deferred Revenue too high?
OPKO Health's current Current Deferred Revenue is MXN0 Mil. Overall, OPKO Health has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does OPKO Health's Current Deferred Revenue compare to CSTL and FRNM?
OPKO Health's Current Deferred Revenue of MXN0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Medical Diagnostics & Research company?
A good Current Deferred Revenue depends on the Medical Diagnostics & Research industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on OPKO Health and its competitors. OPKO Health's current Current Deferred Revenue is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OPKO Health stock overvalued right now?
Based on GuruFocus' analysis, OPKO Health (MEX:OPK) is currently considered Significantly Overvalued. The stock's GF Value™ is MXN14.54, compared to a current price of MXN26.20 — trading 80.2% above its estimated fair value. The current Current Deferred Revenue is MXN0 Mil. OPKO Health's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For OPKO Health (MEX:OPK), the current Current Deferred Revenue is MXN0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OPKO Health (MEX:OPK) Overvalued in 2026?

Based on GuruFocus' analysis, OPKO Health stock appears to be overvalued. The current stock price of MXN26.20 is trading 80.2% above its estimated GF Value™ of MXN14.54. GuruFocus considers OPKO Health to be Significantly Overvalued.

Key valuation signals for MEX:OPK:

  • Current Deferred Revenue: MXN0 Mil
  • GF Value™: MXN14.54 vs. price of MXN26.20 (80.2% above fair value)
  • GF Score™: 44/100 with 5 warning signs

No single metric tells the full story. See the MEX:OPK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OPKO Health Business Description

Address 4400 Biscayne Boulevard, Miami, FL, USA, 33137
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.
44GF Score

Get the complete analysis for MEX:OPK

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN26.20
Price
MXN14.54
GF Value